Vitamin D drops overdose in infants: case reports and the AAP warning

Vitamin D drops are recommended for every breastfed infant in the U.S. and Canada at 400 IU/day from the first days of life. The supplementation is essential. The dosing accuracy is not always reliable. A consistent thread in pediatric case reports over the past decade is iatrogenic vitamin D toxicity in infants from concentrated-formula misuse, dropper miscalibration, or persistent use of adult-strength drops. Understanding where the dosing errors come from is more useful for parents than reciting the recommended dose.

What the right dose actually is

The AAP recommends 400 IU vitamin D3 daily for all breastfed and partially breastfed infants from the first few days of life, and for formula-fed infants consuming less than 1,000 mL of vitamin D-fortified formula per day [1]. The dose remains 400 IU through the first year. Above age 1, the recommendation increases to 600 IU/day. The U.S. tolerable upper intake level for infants 0-6 months is 1,000 IU/day and for infants 6-12 months is 1,500 IU/day, well below acutely toxic doses but with little headroom for prolonged dosing errors.

The dropper-strength problem

Several U.S. and European manufacturers sell concentrated vitamin D3 drops at 1,000 IU per drop or 2,000 IU per drop, intended for adult dosing. When these are inadvertently used for infants instead of the 400 IU/dropperful pediatric formulation, the result is 10-100x the intended dose. A 2013 case series from the Canadian Paediatric Society described 8 infants with symptomatic hypercalcemia after parents misread or were confused by labeling on adult-strength drops [2]. A 2020 European multi-center analysis of 27 cases of pediatric vitamin D toxicity found that compounding pharmacy errors and confusion between drop concentrations accounted for 70% of cases [3].

What hypercalcemia looks like in an infant

Symptomatic vitamin D toxicity in infants typically presents 2-6 weeks after the start of an excessive intake. Clinical features include poor feeding, vomiting, constipation, failure to thrive, irritability, dehydration, and in severe cases nephrocalcinosis and acute kidney injury [4]. Serum calcium above 12 mg/dL with elevated 25(OH)D (typically above 200 nmol/L) confirms the diagnosis. Treatment is removal of the source, IV fluids, and in severe cases bisphosphonates or glucocorticoids. Most cases resolve over weeks to months, but nephrocalcinosis can persist.

Manufacturing and labeling failures

In 2010, the FDA issued warnings to several manufacturers of liquid vitamin D drops for infants after reports that some products' droppers delivered up to 10 times the labeled dose due to design flaws [5]. The agency recommended that all infant vitamin D droppers deliver only 400 IU in a single dropperful and that bottles include integrated dose-limiting features. Subsequent manufacturer redesigns have reduced but not eliminated the error. Compounded vitamin D products for special situations (rickets treatment, malabsorption) are typically prepared at higher concentrations and require careful parent education to avoid confusion.

Recent loading-dose practice

Some clinicians use single high-dose vitamin D loading regimens (50,000-200,000 IU) for rapid repletion in older children and adults. These regimens have not been validated for infants and have produced acute toxicity in case reports when extrapolated downward without dose adjustment. The AAP and Endocrine Society guidelines recommend daily dosing for infant supplementation and reserve high-dose protocols for biochemically confirmed deficiency in older children under specialist supervision [6].

Bottom line

Breastfed infants need 400 IU/day of vitamin D. The risk is not under-supplementation in most U.S. households; it is dropper confusion between infant and adult formulations. Parents should buy only pediatric-strength drops delivering 400 IU per stated dose, store adult vitamin D products separately, never use compounded drops without explicit pediatrician instructions, and call poison control or a clinician if accidental high-dose exposure occurs.